XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
  Autoimmune Diseases
  Immunosupressants
  Monoclonal Antibodies
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
 
 India
Search

Last Updated: Nov 18, 2006 - 12:32:53 PM

Immunology Channel
subscribe to Immunology newsletter

Latest Research : Immunology

   DISCUSS   |   EMAIL   |   PRINT
Infant transplant patients resist infections in immunodeficient states
Jan 31, 2006 - 7:32:00 PM, Reviewed by: Dr. Priya Saxena

The findings are important because they show the immune system is more adaptable and resourceful than once thought. Something other than T cells is working to resist viruses in the post-transplant patients.

 
Investigators have discovered that some type of protective system goes into action in some cases when a baby's immune system is deficient. This discovery indicates a hidden safety net that might have far-reaching consequences for treating diseases of the immune system such as AIDS. The Mayo Clinic-led study was conducted with colleagues in Toronto and Baltimore, and is reported in the early online edition of the Feb. 1 Journal of Immunology.

The researchers studied 20 patients who as infants underwent heart transplantation and had their thymus removed. As a result the infants were deficient in T cells, the cells depleted in AIDS patients that are crucial to fighting viruses and cancer tumors. The researchers found that over a 10-year-period the infant transplant patients resisted the same infections that often kill adult AIDS patients. The transplant patients maintained their health even with low T cell counts. The finding could help improve treatments of AIDS, cancers and diseases of aging related to declining function of the immune system.

"We are very excited by this result," says Jeffrey Platt, M.D., the Mayo transplant researcher who led the team. "This will be the first step to discovering how to make the immune system work in patients who have severe defects in their immune systems or who have cancer."

The Mayo Clinic researchers report results comparing T cell function between transplant patients 1-10 years post transplant and healthy people matched to the transplant patients by age and gender. To compare T cell function, they measured the T cell response to select viral immunization. This comparison enabled them to see that infant heart transplant patients had more help from the immune system post transplant -- even though some had a 10,000-fold reduction in T cells -- compared to the healthy control group. The nature of the compensating system is not yet known and is under study.

The findings are important because they show the immune system is more adaptable and resourceful than once thought. Something other than T cells is working to resist viruses in the post-transplant patients.

The findings also suggest an intriguing strategy for developing new treatments for AIDS, cancers and diseases of impaired immune function related to aging. If this ability of infant-transplant patients' immune systems can be identified and enlisted to fight viruses without T cells, it perhaps could be therapeutically manipulated in adult patients to arrive at new and better treatments for various diseases involving immune system deficiencies.

"We were struck by the fact that when a heart transplant is carried out in very young infants, the thymus that produces T cells is removed and a drug is given that depletes T cells," said Dr. Platt. "Yet the infants don't get the same diseases that adult AIDS patients do, even though the transplanted infants are basically a model of AIDS. In fact, the post-transplant patients do very well resisting infections. It seemed to us very important to understand why this is so, because maybe that would help us help people with age-related diseases caused by declining immunity, or AIDS, or cancers, and understand why certain people tend to be more susceptible to infections."

All healthy people have cells (lymphocytes) with receptors on their surfaces enabling them to recognize many different microorganisms. The diversity of lymphocytes is enormous. Each person has an estimated 1 billion different T cells capable of fighting various infections and another 1 billion of a different kind of immune system cell, the B cell, which produces antibodies. Yet, when the Mayo researchers looked at the immune system of infant heart transplant patients, they found that post transplant the infants have as few as 1,000 T cells -- one ten-thousandth of a healthy immune system. Immunologically, they are the equivalent of AIDS patients -- perhaps even more vulnerable to infectious diseases. Yet 10 years post transplant, the patients don't suffer from infections as AIDS patients do.

So promising is the work that it recently garnered a $6 million grant from the National Institutes of Health to support further research into the roles of T cells, B cells and antibody production in the outcomes of pediatric heart transplants. "We're very excited about this opportunity to expand the current understanding of the human immune system -- and hopefully, in the process, discover new treatments for debilitating diseases," says Dr. Platt.
 

- Feb. 1 Journal of Immunology
 

Link to the Reaserch Article

 
Subscribe to Immunology Newsletter
E-mail Address:

 

Others researchers at Mayo Clinic included: Brenda Ogle, Ph.D.; Raymund Razonable, M.D.; Carlos Paya, M.D., Ph.D.; and Marilia Cascalho, M.D., Ph.D. From the Hospital for Sick Children Research Institute and the University of Toronto, Toronto, Ontario, Canada, Lori West, M.D., D.Phil., participated. From the University of Maryland, Baltimore, Scott Strome, M.D., participated. The work was supported by a grant from the National Institutes of Health.

Related Immunology News

Pregnant women with lupus are at higher risk for complications
Molecular 'signature' protects cells from viruses
Discovery in the evolution of the immune system absorbing cells
Leeds University study shows eculizumab may be an effective therapy for PNH
Research Reveals Inner Workings of Immune System �Thermostat�
CD23 Protein in Stool Samples may Indicate Food Allergy
Molecular signals triggering maturation of natural killer cells uncovered
New method to analyse the Major Histocompatibility Complex (MHC) of the human genome
Front Line Immune Cells Mature in Four Stages - Study
Caspase-12 gene that shuts down immune system is found in 20% of people of African descent


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us